Quantcast Profile: Rxelite Holdings
Search by tag or site Login to my blog ? Start my own blog














TheMoneyBlogs
Home
About
Create your own blog
Contact us
Vote for this blog!

BioHealth Investor

BioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network.

Profile: Rxelite Holdings

Posted on 09/21/2007 07:22:28 | Link | Post Comment
BHI Company Directory Profile




RxElite Holdings
1404 North Main Street
Suite 200
Meridian, Idaho 83642
U.S.A.
Phone: 800-414-1901
Fax: (208) 288-1191
consumercare@rxelite.com




RxElite Holdings, Inc. (SOUT.OB) is a specialty pharmaceutical company that develops, manufactures, and markets generic prescription drug products in specialty generic markets. These markets include products in the areas of anesthesia, sterile liquid dose drugs (including respiratory inhalation drugs, ophthalmics, and injectable drugs), and transdermal patch products.

By utilizing "best in class" manufacturing and research and development partners, RxElite has created a dynamic, integrated team with a deep knowledge of the generic prescription pharmaceutical market. RxElite has built a strong base in sterile liquid dose manufacturing and is continuing to add select oral solid dose manufacturing capabilities.

The RxElite management team brings together experience in customer relationship management, pharmaceutical manufacturing, generic pharmaceutical development, supply chain management, and finance.

Founded in December 2000, RxElite has built significant sales and distribution channels in the U.S. Market. RxElite has implemented an aggressive generic product development and launch plan that will considerably strengthen our product portfolio over the next five years, through internal ANDA registrations and growing our partnerships with major international generic manufacturers.

Positioned as a strong player in the generic pharmaceutical market, RxElite is committed to providing the highest quality products at the best prices, with 100% deliverability.

We are committed to provide the following benefits to our clients and their customers:

Quality - RxElite products meet or exceed the industry's highest quality standards ensuring long-term satisfied customers.
Price - Utilizing the latest manufacturing technology and low cost distribution methods, RxElite is positioned to maintain price leadership.
Deliverability - RxElite has maintained a 100% order fulfillment rate since inception and will continue to strive to meet this standard.
RxElite's end goal: To be the generic buyer's "vendor of choice" in each of our products.






This is a BioHealth Investor company profile. Promote your company, learn how...
____________________
Stock Quote or
Examples
Morpheus Trading - Thu Jul 17, 2008 01:15AM
NOTE: Please click on the charts below to enlarge them if th [read more]
Morpheus Trading - Tue Jul 15, 2008 08:25AM
NOTE: Please click on the charts below to enlarge them [read more]
Morpheus Trading - Mon Jul 14, 2008 02:18AM
NOTE: Please click on the charts below to enlarge them if [read more]

PREMIER SPONSORED LINKS

Most Visited Blogs | Most Popular Blogs | Most Recent Blogs | Contact Us | Terms and conditions | Privacy Policy

The columns, articles, message board posts and any other features provided on TheMoneyBlogs.com are provided for personal finance, education and investment information and are not to be construed as investment advice. Under no circumstances does the information in this content represent a recommendation to buy, sell or hold any security. The views and opinions expressed in an article or column are the author's own and not necessarily those of TheMoneyBlogs.com and there is no implied endorsement by TheMoneyBlogs.com of any advice or trading strategy. The analysts and employees or affiliates of TheMoneyBlogs.com may hold positions in the stocks or industries discussed here. Your use of this and all information contained on TheMoneyBlogs.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

Copyright © 2008 The Connors Group, Inc.